We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » HHS RECOMMENDS FINANCIAL INTEREST OVERSIGHT PANELS FOR DRUG TRIALS
HHS RECOMMENDS FINANCIAL INTEREST OVERSIGHT PANELS FOR DRUG TRIALS
May 14, 2004
The HHS Office of Public Health and Science has recommended in a new final guidance document that institutions involved in FDA-regulated clinical research establish conflict of interest committees (COICs) to verify whether the institution or individual investigators have a financial stake in the outcome of the research.